The CD40-CD40L system in cardiovascular disease. (Q37829738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

The CD40-CD40L system in cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

cardiovascular disease

1 reference

based on heuristic

inferred from title

author

Viktor A. Snezhitskiĭ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Eduard Shantsila

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

Gregory Y H Lip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

Burak Pamukcu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

18 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

331-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Induction of human IgE synthesis in B cells by mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 ligand is functionally expressed on human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Molecular and biological characterization of a murine ligand for CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Cloning of TRAP, a ligand for CD40 on human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

The CD40/CD154 receptor/ligand dyad

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Internalization of CD40 regulates its signal transduction in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 signaling and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

TNF-receptor-associated factors as targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Differential regulation of soluble and membrane CD40L proteins in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Immune regulation by CD40 and its ligand GP39.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

T cells in atherogenesis: for better or for worse?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40L: risk prediction after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Requirement for CD154 in the progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.546362

10.3109/07853890.2010.546362

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21244217%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference